购物车
- 全部删除
- 您的购物车当前为空
EMI48, a derivative of EMI1, exhibits increased efficacy against mutant EGFR compared to EMI1. It specifically inhibits EGFR triple mutants [1].
为众多的药物研发团队赋能,
让新药发现更简单!
EMI48, a derivative of EMI1, exhibits increased efficacy against mutant EGFR compared to EMI1. It specifically inhibits EGFR triple mutants [1].
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 1,670 | 5日内发货 | |
5 mg | ¥ 2,490 | 5日内发货 | |
25 mg | ¥ 8,930 | 6-8周 | |
50 mg | ¥ 11,600 | 6-8周 | |
100 mg | ¥ 16,600 | 6-8周 | |
1 mL x 10 mM (in DMSO) | ¥ 2,730 | 5日内发货 |
产品描述 | EMI48, a derivative of EMI1, exhibits increased efficacy against mutant EGFR compared to EMI1. It specifically inhibits EGFR triple mutants [1]. |
体外活性 | EMI48 inhibits EGFR ex19del/T790M/C797S and EGFR L858R/T790M/C797S. EMI48 can be used in the research of mutant EGFR-associated, drug-resistant non-small-cell lung cancer (NSCLC) [1]. |
分子量 | 348.4 |
分子式 | C21H20N2O3 |
CAS No. | 34564-13-1 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容